Coppell Advisory Solutions LLC Glaukos Corp Transaction History

Coppell Advisory Solutions LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $1,799 - $2,056	26 Added 61.9%	68 $432,000
Q2 2023 Aug 17, 2023	BUY	$45.44 - $71.21 $1,908 - $2,990	42 New	42 $242,000
Q1 2023 May 19, 2023	SELL	$43.88 - $52.48 $2,808 - $3,358	-64 Closed	0 $0
Q4 2022 May 19, 2023	BUY	$40.82 - $57.75 $2,612 - $3,696	64 New	64 $407,000

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.79B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Coppell Advisory Solutions LLC with notifications on news.